WHO / Panos / Eduardo Martino
Health professional uses a lancet to prick the finger of pregnant and diabetic person. Glucose levels and blood pressure measurement monitoring at CEDEBA.
© Credits

Strengthening diagnostics capacity

Whilst approximately 70% of healthcare decisions are made based on diagnostic test results, only 3–5% of healthcare budgets go to diagnostic services. In many countries clinicians don’t have access to basic diagnostic tools or laboratory tests needed to support patients. When they are available, vast distances and isolated communities often make testing people extremely difficult.

Recognizing the importance of access to diagnostics, a new resolution was adopted by the World Health Assembly (WHA76.5) in May 2023 to strengthen global diagnostics capacities. In response, WHO established the Diagnostics Taskforce as a collaborative mechanism between all WHO programmes, at all three levels of the organization, to support the implementation of the resolution, and to serve as the entry point to all stakeholders working with countries on strengthening diagnostics capacity.

Taskforce members support countries in assessing national needs for diagnostic technologies (including medical devices), ensuring quality, and providing implementation guidance, particularly in low-resource settings. They offer advice on selecting and prioritising essential diagnostics and help strengthen health systems, including national laboratory systems. Additionally, they provide training for the healthcare workforce to use diagnostics effectively, from primary care to complex procedures requiring specialised skills.

Publications

All →
Antimicrobial Resistance Diagnostic Initiative

WHO Antimicrobial Resistance (AMR) Diagnostic Initiative builds on the resolution WHA76.5 (2023) “strengthening diagnostic capacity” adopted...

Landscape analysis of commercially available and pipeline in vitro diagnostics for fungal priority pathogens

This report presents the first World Health Organization (WHO) analysis of commercially available diagnostic products and pipeline diagnostic products...

Global research agenda for antimicrobial resistance in human health

The World Health Organization's global research agenda for antimicrobial resistance in human health is the first of its kind, developed to promote the...

The selection and use of essential in vitro diagnostics: report of the fourth meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2022 (‎including the fourth WHO model list of essential in vitro diagnostics)‎

The Technical report of the fourth meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2022 (including the fourth WHO model...

Multimedia

Other Resources

The electronic WHO Model List of Essential in vitro Diagnostics (eEDL) 

electronic essential diagnostic list graphic

The eEDL (electronic essential in vitro diagnostic list) is an open access electronic database of in vitro diagnostics. The eEDL compiles the diagnostics that appear in the WHO model list of essential in vitro diagnostics.

 

Priority Medical Devices Information System (MeDevIS) 

Medevis database graphic

MeDevIS (Priority Medical Devices Information System) is an open access electronic database of medical devices. WHO developed it as part of a mandate of Member States ( WHA60.29*). MeDeVIS encompass the devices that appear in all WHO Priority Medical Devices List (MDL) and other WHO related products.

Contact us

The WHO Diagnostic Task Force includes senior management, a coordination group and 5 working groups:  advocacy; country strategy and support; technical issues; resource mobilization and; resolution implementation workplan.  

If you are a stakeholders working with countries on strengthening diagnostics capacity contact us using the email below.